Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report preliminary results for the fourth quarter and fiscal year ended December 31, 2014, as well as a business update after the market close on Wednesday, January 28, 2015. The company will also hold a live investor conference call and webcast at 5:00pm Eastern/2:00pm Pacific. Conference Call & Webcast Wednesday, January 28, 2015 @ 5:00pm Eastern Time/2:00pm Pacific Time Domestic: 888-430-8709 International: 719-325-2484 Passco… Read more »
Shares of Nanosphere opened today at $0.236 . NSPH has a 1-year high of $2.69 and a 1-year low of $0.22. The stock’s 50-day moving average is $0.36 and it’s 200-day moving average is $0.67.
On the ratings front, Nanosphere has been the subject of a number of recent research reports. In a report issued on November 20, Roth Capital analyst Chris Lewis reiterated a Buy rating on NSPH.
Nanosphere, Inc., develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, which enables sensitive genomic and protein testing on a single platform.